Security key
230031106
Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM)
CUSIP: 230031106
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 62,610,123
- Total 13F value
- $471,432,056
- Share change
- -2,064,371
- Put/Call ratio
- 8652%
- SEC-reported price per share
- $7.53
- Number of holders
- 141
- Value change
- -$15,598,491
- Number of buys
- 68
- Number of sells
- 67
- Shares outstanding
- 61,676,366
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
141
Top holders
10
CGEM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Cullinan Therapeutics, Inc. SEC filings
Cullinan Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 230031106
Recent filing periods:
Ownership snapshot
Top reported holders of CGEM - Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FRANKLIN RESOURCES INC
Disclosed value leader
MPM BioImpact LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 3.8%
13D/G row: FRANKLIN RESOURCES INC
Showing 1-6 of 15 holder rows.
Quick read
FRANKLIN RESOURCES INC leads the comparable SEC ownership view at 3.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FRANKLIN RESOURCES INC's linked filing trail.
Comparable ownership
Top 5
FRANKLIN RESOURCES INC
3.8%
MPM BioImpact LLC
12%
BVF INC/IL
9.3%
BlackRock, Inc.
6.8%
DEERFIELD MANAGEMENT COMPANY, L.P.
6.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC |
13D/G
13F
Company
|
3.8%
|
$17,836,873
2,191,262 shares
|
$0 | 30 Sep 2024 |
| MPM BioImpact LLC |
13F
Company
|
12%
|
$57,897,389
7,648,268 shares
|
— | 31 Mar 2025 |
| BVF INC/IL |
13F
Company
|
9.3%
|
$43,532,670
5,750,683 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
6.8%
|
$31,951,923
4,220,862 shares
|
— | 31 Mar 2025 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
6.3%
|
$29,226,551
3,860,839 shares
|
— | 31 Mar 2025 |
| Lynx1 Capital Management LP |
13F
Company
|
5.2%
|
$24,343,016
3,215,722 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
141
Shares
62,610,123
Rows available
141
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
145
Q2 2025 holders
141
Holder diff
-4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend